Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:26 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1441–1464 of 5,304 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Individual Therapy Clear all

Conditions: Ascites, Cirrhosis
Interventions: Residency Program Teaching, Lecture, Pocket Card Reference, Pager; Behavioral · Other
Lead sponsor: Boston Medical Center; Other
Eligibility: Not listed
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Addiction, Opioid
Interventions: Enhanced Monitoring and Feedback (EMF), NIATx/MAT Academy, NIATx-Internal Facilitation (NIATx-IF), NIATx-External Facilitation (NIATx-EF); Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Olympia, Washington

Conditions: Hiv
Interventions: Data to Suppression (D2S), Usual practice; Other
Lead sponsor: City University of New York; Other
Eligibility: Not listed
Enrollment: 1,494 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 27
States / cities: New York, New York

Conditions: Lung Cancer
Interventions: Light Physical Activity, Symptom Experience Report; Behavioral · Other
Lead sponsor: Michigan State University; Other
Eligibility: 21 Years and older
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 4
States / cities: East Lansing, Michigan • Grand Rapids, Michigan • Lansing, Michigan

Conditions: Adolescent Obesity
Interventions: Lifestyle Modification Therapy (LSMT), Phentermine Pill, Topiramate Pill, Placebo; Behavioral · Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 12 Years to 17 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Crohn Disease
Interventions: BI 706321, Ustekinumab, Placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 15
States / cities: Northridge, California • Hialeah, Florida • Inverness, Florida + 12 more

Conditions: Healthy Volunteers
Interventions: BPT, NP; Other
Lead sponsor: Lumos Labs, Inc.; Industry
Eligibility: 70 Years to 89 Years
Enrollment: 229 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 3
States / cities: Garden Grove, California • Oakland, California • Torrance, California

Conditions: Injection Site Infection, Substance Use Disorders
Interventions: SIRI Team, Treatment as Usual; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 6
States / cities: Birmingham, Alabama • Miami, Florida • Tampa, Florida + 3 more

Conditions: Healthy
Interventions: Canagliflozin, 100 mg, Metformin XR, 500 mg, CANA/MET XR FDC, Formulation 1, 50 mg/1000 mg, CANA/MET XR FDC, Formulation 2, 50 mg/1000 mg; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: COVID-19
Interventions: nirmatrelvir-ritonavir; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 14,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Med-eMonitor, PharmCAT, Treatment as Usual; Behavioral
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 60 Years
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Obesity
Interventions: TAP® Micro Select Device (Touch Activated Phlebotomy); Device
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Medford, Massachusetts

Conditions: Smoking Cessation, Smoking Behaviors, Smoking, Tobacco, Smoking, Cigarette, Smoking (Tobacco) Addiction
Interventions: ACT Lung Health Intervention; Behavioral
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years to 100 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Arthritis Foot, Trauma Injury, Deformity; Bone
Interventions: NanoBone Bone Graft Substitute; Other
Lead sponsor: Artoss Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 8
States / cities: Scottsdale, Arizona • Sarasota, Florida • Joliet, Illinois + 5 more

Conditions: Bipolar Disorder, Bipolar I Disorder
Interventions: Psychiatric management, Psychosocial treatment, LiveWell Program; Other · Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 205 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 2
States / cities: Chicago, Illinois • Bloomington, Minnesota

Conditions: Posttraumatic Stress Disorder, Depression
Interventions: Self-Help Cognitive Processing Therapy, Women Veterans Network (WoVeN), Treatment as Usual; Behavioral · Other
Lead sponsor: Boston University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hodgkin's Disease, Non-Hodgkin's Lymphoma
Interventions: Vorinostat, Niacinamide, Etoposide; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Spinal Cord Injuries (Complete and Incomplete)
Interventions: Transauricular vagus nerve stimulation; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 89 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Hairy Cell Leukemia
Interventions: Vemurafenib, Obinutuzumab, Cladribine, Rituximab; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 10
States / cities: Boston, Massachusetts • Rochester, Minnesota • Basking Ridge, New Jersey + 7 more

Conditions: Smoking Cessation, Tobacco Use Disorder, Smoking, HIV, AIDS, Pharmacy
Interventions: ENgaging pHarmacists to AdvANCE Tobacco Treatment Service delivery (ENHANCE-TTS); Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years and older
Enrollment: 172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Hepatitis C, Drug Use
Interventions: Rapid Treatment strategy, Usual Care (facilitated referral); Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 29 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Type 1 Diabetes Mellitus
Interventions: Insulin glargine, 300 units per milliliter (U/mL), Background therapy: Rapid Acting meal time insulin analogs (Humalog, Novolog or Apidra); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 3
States / cities: West Des Moines, Iowa • Houston, Texas • Bridgeport, West Virginia

Conditions: Alcohol Use Disorders
Interventions: Intensive Motivational Interviewing, Single session of Motivational Interviewing; Behavioral
Lead sponsor: Public Health Institute, California; Other
Eligibility: 18 Years and older · Female only
Enrollment: 215 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Lafayette, California

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Reassure Non-Contact Respiration Monitor; Device
Lead sponsor: ResMed; Industry
Eligibility: 35 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Search by objective public record fields.

Improving Performance of Paracentesis in Medical Residency Training

Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)

Testing a Novel Data-to-Suppression (D2S) Intervention Strategy in the Ryan White HIV/AIDS Program

The Symptom Experience Study in Persons With Non-Small Cell Lung Cancer

SMART Use of Medication for the Treatment of Adolescent Severe Obesity

A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease

Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults

Integrated Care and Treatment for Severe Infectious Diseases and Substance Use Disorders Among Hospitalized Patients

A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants

A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.

Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia

A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Loss

ACT Lung Health Intervention: Phase Two

Artoss Foot and Ankle Surgery Registry

LiveWell: A Mobile Intervention for Bipolar Disorder

Self-Help Cognitive Processing Therapy (CPT)/Women Veterans Network (WoVeN) Study

Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies

Pilot Testing of Vagus Nerve Stimulation for Early Spinal Cord Injury Recovery

A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)

Engaging Pharmacists to Advance Tobacco Treatment Service Delivery

HCV Seek, Test and Rapid Treatment for Young PWID

Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy)

Randomized Trial of Intensive Motivational Interviewing (IMI) to Improve Drinking Outcomes Among Women

Respiration Rate Monitoring in COPD Patients